Fry Norman K, Tzivra Oceanis, Li Y Ting, McNiff Anthony, Doshi Nivedita, Maple P A Christopher, Crowcroft Natasha S, Miller Elizabeth, George Robert C, Harrison Timothy G
Respiratory and Systemic Infection Laboratory1 and Special Projects Laboratory2, Specialist and Reference Microbiology Division, Health Protection Agency, 61 Colindale Avenue, London NW9 5HT, UK 3Health Protection Agency, Immunization Division, Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5HT, UK.
J Med Microbiol. 2004 Jun;53(Pt 6):519-525. doi: 10.1099/jmm.0.45624-0.
This study reports on practical laboratory aspects of pertussis diagnosis. PCR assays were applied to respiratory specimens obtained during a large study of infants (less than 5 months old) admitted to paediatric intensive care units (n = 122), children (less than 15 years old) admitted to paediatric wards (n = 16) and their household contacts (n = 320). Estimation of antibodies to pertussis toxin and culture for Bordetella pertussis were attempted on specimens from the same patients, where available, and the overall utility of the diagnostic PCR assays was assessed by comparison to these results. A PCR assay for the human mitochondrial cytochrome oxidase (HMCO) gene was used for quality control of the extracted samples and an internal process control (IPC) was included in each sample to test for PCR inhibition. Four of 458 samples were considered unsuitable (three HMCO negative, one IPC negative) and excluded from further analyses. Positive PCR results were considered valid if they were either (i) positive for both of two B. pertussis gene targets (pertussis toxin S1 promoter and the insertion element IS481), i.e. consensus PCR positive, or (ii) repeatably positive in only one assay. Using these criteria, 52 of 454 (11.5 %) samples were considered as PCR positive for B. pertussis. Six of 356 samples were culture-positive for B. pertussis, 1/88 infants, 3/14 children and 2/254 contacts, giving an overall isolation rate of 1.7 %. Using these data, PCR gave an almost fivefold increase in diagnostic yield compared with culture (McNemar's test; P < 0.0001). Sera from 9/111 infants, 5/10 children and 14/210 contacts were positive. Serology and PCR results showed a high level of agreement (113/121) for infants and children. PCR demonstrated a significant improvement in diagnostic yield over culture. Serological testing also resulted in a significant increase in diagnostic yield compared to culture alone. PCR is a useful technique, but validity of results must be assured by careful control. Rapid diagnosis of B. pertussis infection particularly in infants by PCR, together with serological assays, can enhance surveillance systems for pertussis in all age groups.
本研究报告了百日咳诊断的实际实验室情况。聚合酶链反应(PCR)检测应用于在一项大型研究中采集的呼吸道标本,该研究对象包括入住儿科重症监护病房的婴儿(小于5个月,n = 122)、入住儿科病房的儿童(小于15岁,n = 16)及其家庭接触者(n = 320)。在可行的情况下,对来自同一患者的标本进行百日咳毒素抗体检测和百日咳博德特氏菌培养,并通过与这些结果进行比较来评估诊断性PCR检测的整体效用。使用针对人类线粒体细胞色素氧化酶(HMCO)基因的PCR检测对提取的样本进行质量控制,并且在每个样本中包含内部过程对照(IPC)以检测PCR抑制情况。458个样本中有4个被认为不适合(3个HMCO阴性,1个IPC阴性),并被排除在进一步分析之外。如果PCR结果满足以下任一情况,则被认为有效:(i)两个百日咳博德特氏菌基因靶点(百日咳毒素S1启动子和插入元件IS481)均为阳性,即共识PCR阳性,或(ii)仅在一次检测中反复呈阳性。根据这些标准,454个样本中有52个(11.5%)被认为百日咳博德特氏菌PCR检测呈阳性。356个样本中有6个百日咳博德特氏菌培养阳性,分别为1/88名婴儿、3/14名儿童和2/254名接触者,总体分离率为1.7%。根据这些数据,与培养相比,PCR的诊断率提高了近五倍(McNemar检验;P < 0.0001)。111名婴儿中的9名、10名儿童中的5名和210名接触者中的14名血清学检测呈阳性。婴儿和儿童的血清学和PCR结果显示出高度一致性(113/121)。PCR显示出在诊断率方面比培养有显著提高。与单独培养相比,血清学检测也使诊断率显著提高。PCR是一项有用的技术,但必须通过仔细控制来确保结果的有效性。通过PCR以及血清学检测快速诊断百日咳博德特氏菌感染,尤其是在婴儿中,可以加强所有年龄组的百日咳监测系统。